Related Experiment Videos
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis
Raed Alroughani1, Jihad Inshasi2,3, Abdullah Al-Asmi4
1Department of Medicine, Amiri Hospital , Sharq, Kuwait.
Postgraduate Medicine
|February 25, 2020
Abstract:
Recent research has expanded our understanding of the natural history and clinical course of multiple sclerosis (MS) in the Arabian Gulf region. In addition, the number of available therapies for MS has increased greatly in recent years, which complicates considerably the design of therapeutic regimens. We, an expert group of physicians practising in Arabian Gulf countries, present pragmatic consensus recommendations for the use of disease-modifying therapy, according to the level of MS disease activity, according to objective criteria, and prior treatment (if any) received by a given patient.